Irlanda - inglés - HPRA (Health Products Regulatory Authority)

norton healthcare limited t/a ivax pharmaceuticals uk - salbutamol sulfate - nebuliser solution - 2.5/2.5 mg/ml - salbutamol

Canadá - inglés - Health Canada

glaxo canada inc - salbutamol (salbutamol sulfate) - liquid - 1mg - salbutamol (salbutamol sulfate) 1mg - selective beta 2-adrenergic agonists

Canadá - inglés - Health Canada

glaxosmithkline inc - salbutamol (salbutamol sulfate) - solution - 0.25mg - salbutamol (salbutamol sulfate) 0.25mg - selective beta 2-adrenergic agonists

Australia - inglés - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 2.4 mg/ml (equivalent: salbutamol, qty 2 mg/ml) - inhalation - excipient ingredients: sodium chloride; sulfuric acid; water for injections - indications as at 1st february 1999: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 1.2 mg/ml (equivalent: salbutamol, qty 1 mg/ml) - inhalation - excipient ingredients: sodium chloride; water for injections; sulfuric acid - indications as at 1st february 1999: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 6 mg/ml (equivalent: salbutamol, qty 5 mg/ml) - inhalation - excipient ingredients: purified water; benzalkonium chloride; sulfuric acid - indications as at 1st february 1999: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Canadá - inglés - Health Canada

pharmascience inc - salbutamol (salbutamol sulfate) - solution - 0.4mg - salbutamol (salbutamol sulfate) 0.4mg - selective beta 2-adrenergic agonists

Canadá - inglés - Health Canada

ratiopharm inc division of teva canada limited - salbutamol (salbutamol sulfate) - metered-dose aerosol - 100mcg - salbutamol (salbutamol sulfate) 100mcg - selective beta 2-adrenergic agonists

Canadá - inglés - Health Canada

pharmel inc - salbutamol (salbutamol sulfate) - solution - 0.4mg - salbutamol (salbutamol sulfate) 0.4mg - selective beta 2-adrenergic agonists

Canadá - inglés - Health Canada

sanis health inc - salbutamol (salbutamol sulfate) - metered-dose aerosol - 100mcg - salbutamol (salbutamol sulfate) 100mcg - selective beta 2-adrenergic agonists